Chiasso, Switzerland – 21 May 2026 – Dipharma SA, a Swiss pharmaceutical company developing high-quality, improved medicines for rare diseases, is proud to announce that it has been ranked #7 in the Top Workplaces in Europe 2025 list by Best Places to Work.

The recognition marks Dipharma’s second consecutive year in the Top 10, confirming its place among Europe’s leading employers. The 2025 ranking honors organizations across the region that have demonstrated outstanding commitment to workplace excellence, employee engagement and leadership.

The European result builds on a consistent track record at national level: Dipharma has been certified as one of the Best Places to Work in Switzerland for four consecutive years, with 100% of employees rating the company as an excellent employer in the two most recent surveys.

 For Dipharma, this result reflects a culture built on trust, collaboration and shared purpose — a workplace where people feel valued and empowered to contribute to meaningful solutions for patients affected by rare diseases.

 “Being recognized among the Top 10 Best Workplaces in Europe for the second year in a row is a significant milestone for Dipharma,” said Fabio Cannata, General Manager of Dipharma SA. “This is a credit to our people. Their professionalism and commitment to our purpose are what allow us to keep growing as a company while staying focused on our mission: improving the lives of patients with rare diseases.”

 “At Dipharma, our values guide how we work: quality at the center, teamwork, and the motivation and passion our people bring every day,” said Angela Tanieli, Director of Human Resources. “This recognition tells us those values are not just written down — they are lived, in how colleagues support each other and in the careers people choose to build here.”

 “A company is only as strong as the people who lead it and the people who choose to stay and grow within it,” said Marc-Olivier Geinoz, founder and Chairman of Dipharma SA. “This ranking confirms what I see every time I meet with our teams: a management group that leads with competence and integrity, and a workforce that is engaged, capable and committed to our mission. Sustaining this kind of environment is one of the most important responsibilities of any board, and I am proud of how our leadership team continues to deliver on it.”

About Dipharma

Dipharma SA is a Swiss specialty pharmaceutical company developing high-quality, improved medicines for rare diseases. It is part of a third-generation group of family-owned companies with a global presence.

With a portfolio of specialty medicines for the treatment of Phenylketonuria, Gaucher Disease, Hereditary Tyrosinemia Type 1, Urea Cycle Disorders, and others, Dipharma SA provides innovative and affordable solutions for patients affected by inborn metabolic diseases worldwide.

For more information, please visit www.dipharma.ch.

About Best Places to Work Program

Best Places to Work is a global HR certification program recognizing leading workplaces around the world. Our proprietary assessment analyzes organizations’ attractiveness through a two-step process focusing on 8 workplace factors including culture, leadership, opportunities for growth and people practices. Beside the employee survey, an HR assessment is conducted focusing on evaluating the organization’s HR practices against the best standards.

LinkedIn: https://www.linkedin.com/company/best-places-to-work-program/ 
Twitter: https://twitter.com/bptw4
Facebook: https://www.facebook.com/bptw4all/
For more information, please visit www.bestplacestoworkfor.org

Media contacts: media@bestplacestoworkfor.org | +1 646 980 2510 | +44 208 895 6562 | +65 3159 3656